Author:
Wang Xin,Gao Ming,Zhou Shanshan,Wang Jinwen,Liu Fang,Tian Feng,Jin Jing,Ma Qiang,Xue Xiaodi,Liu Jie,Liu Yuqi,Chen Yundai
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Chen W, Gao R, Liu L, Zhu M, Wang W, Wang Y, et al. China cardiovascular disease report 2014. Chin circ j. 2015;30:617–22.
2. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, et al. ST-segment elevation myocardial infarction in china from 2001 to 2011 (the china PEACE-retrospective acute myocardial infarction study): a retrospective analysis of hospital data. Lancet. 2015;385(9966):441–51.
3. Deutscher S, Ostrander LD, Epstein FH. Familial factors in premature coronary heart disease--a preliminary report from the Tecumseh community health study. Am j epidemiol. 1970;91(3):233–7.
4. Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet. 2009;374(9683):29–38.
5. Sartorio A, Lafortuna CL, Marinone PG, Tavani A, La Vecchia C, Bosetti C. Short-term effects of two integrated, non-pharmacological body weight reduction programs on coronary heart disease risk factors in young obese patients. Diabetes nutr metab. 2003;16(4):262–5.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献